Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

303 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[From the NLST randomized trial to the clinic: how should we implement individual lung cancer screening in clinical practice?].
Couraud S, Barlési F, Lemarié E, Zalcman G, Milleron B; pour le groupe de travail IFCT/GOLF sur le dépistage du cancer broncho-pulmonaire. Couraud S, et al. Among authors: milleron b. Rev Mal Respir. 2013 Jan;30(1):15-7. doi: 10.1016/j.rmr.2012.10.021. Epub 2012 Nov 22. Rev Mal Respir. 2013. PMID: 23318184 French. No abstract available.
[Pleuropulmonary metastases of female cancers].
Lemarié E, Milleron B. Lemarié E, et al. Among authors: milleron b. Rev Pneumol Clin. 1999 Oct;55(5):271-9. Rev Pneumol Clin. 1999. PMID: 10637893 Review. French.
Etoposide plus cisplatin with or without the combination of 4'-epidoxorubicin plus cyclophosphamide in treatment of extensive small-cell lung cancer: a French Federation of Cancer Institutes multicenter phase III randomized study.
Pujol JL, Daurès JP, Rivière A, Quoix E, Westeel V, Quantin X, Breton JL, Lemarié E, Poudenx M, Milleron B, Moro D, Debieuvre D, Le Chevalier T. Pujol JL, et al. Among authors: milleron b. J Natl Cancer Inst. 2001 Feb 21;93(4):300-8. doi: 10.1093/jnci/93.4.300. J Natl Cancer Inst. 2001. PMID: 11181777 Clinical Trial.
Randomised, multicentre phase II study assessing two doses of docetaxel (75 or 100 mg/m2) as second-line monotherapy for non-small-cell lung cancer.
Quoix E, Lebeau B, Depierre A, Ducolone A, Moro-Sibilot D, Milleron B, Breton JL, Lemarie E, Pujol JL, Brechot JM, Zalcman G, Debieuvre D, Vaylet F, Vergnenegre A, Clouet P. Quoix E, et al. Among authors: milleron b. Ann Oncol. 2004 Jan;15(1):38-44. doi: 10.1093/annonc/mdh005. Ann Oncol. 2004. PMID: 14679117 Free article. Clinical Trial.
303 results